Current progress in pathway-targeted therapeutics for Alzheimer’s disease: mechanistic insights and windows of opportunity
Crossref DOI link: https://doi.org/10.1007/s11010-026-05505-1
Published Online: 2026-02-19
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ahmad, Habab Ali
Zafar, Mahnoor
Khan, Tooba
Khan, Muhammad Imran
Text and Data Mining valid from 2026-02-19
Version of Record valid from 2026-02-19
Article History
Received: 18 September 2025
Accepted: 9 February 2026
First Online: 19 February 2026
Declarations
:
: The authors declare no competing interests.